Lynn M. Malec, MD, MSc

Associate Professor

view physician profile

Locations

Froedtert Hospital
Children's Wisconsin - Milwaukee
Children's Wisconsin Clinics - Milwaukee
Cancer Center - Froedtert Hospital

Specialties

Hematology

Languages

English

Cancer Center - Froedtert Hospital

(414) 805-0505

Education

MD - Doctor of Medicine
MSc - Master of Science

Biography

Lynn Malec, MD, MSc, is an Associate Director for Comprehensive Center for Bleeding Disorders at Versiti Blood Center of Wisconsin, and has a joint appointment as an Assistant Professor of Medicine in the Department of Internal Medicine and Pediatrics, and Division of Hematology and Oncology at the Medical College of Wisconsin. She completed her training in Internal Medicine and Pediatrics, and Hematology and Oncology at the University of Pittsburgh Medical Center, Pittsburgh, PA, in 2011 and 2014, respectively. Also in 2014, she received her Masters in Science from the Institute for Clinical Research Education from the same university. Dr. Malec cares for patients with benign hematologic conditions with a clinical area of focus on patients with bleeding and clotting disorders. She conducts clinical research in patients with hemophilia and other inherited bleeding disorders.

Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database.

(Roberts JC, Malec LM, Halari I, Hale SA, Oladapo A, Sidonio RF Jr.) Haemophilia. 2022 Jan;28(1):97-108 PMID: 34761486 PMCID: PMC9299176 11/12/2021
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A.

(Ebbert PT, Xavier F, Malec LM, Seaman CD, Ragni MV.) Thromb Res. 2020 Nov;195:51-54 PMID: 32653601 07/13/2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States.

(Malec LM, Cheng D, Witmer CM, Jaffray J, Kouides PA, Haley KM, Sidonio RF Jr, Johnson K, Recht M, White G, Croteau SE, Ragni MV.) Am J Hematol. 2020 Aug;95(8):960-965 PMID: 32356313 SCOPUS ID: 2-s2.0-85087914846 05/02/2020
Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres.

(Malec LM, Croteau SE, Callaghan MU, Sidonio RF Jr.) Haemophilia. 2020 May;26(3):e128-e129 PMID: 32142196 03/07/2020
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia.

(Croteau SE, Cheng D, Cohen AJ, Holmes CE, Malec LM, Silvey M, Thornburg CD, Wheeler AP, Kouides PA, Raffini LJ, Neufeld EJ.) Haemophilia. 2019 Jul;25(4):668-675 PMID: 30993845 04/18/2019
Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome.

(Malec LM, Cooper J, Rudolph J, Michaels MG, Ragni MV.) J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):972-975 PMID: 29135819 11/15/2017
Feasibility of the Von Willebrand disease PREVENT trial.

(Ragni MV, Machin N, James AH, Seaman CD, Malec LM, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brooks MM.) Thromb Res. 2017 Aug;156:8-13 PMID: 28577390 06/04/2017
Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.

(Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA.) Pediatr Blood Cancer. 2017 Aug;64(8) PMID: 28067012 01/10/2017
Extended half-life factor VIII for immune tolerance induction in haemophilia.

(Malec LM, Journeycake J, Ragni MV.) Haemophilia. 2016 Nov;22(6):e552-e554 PMID: 27640873 09/20/2016
Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein.

(Ragni MV, Alabek M, Malec LM.) Haemophilia. 2016 Sep;22(5):e462-4 PMID: 27501368 08/09/2016
Von Willebrand factor for menorrhagia: a survey and literature review.

(Ragni MV, Machin N, Malec LM, James AH, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brambilla DJ.) Haemophilia. 2016 May;22(3):397-402 PMID: 26843404 PMCID: PMC4874860 02/05/2016
Validation Study of the Composite Score to Identify Von Willebrand Disease in Children.

(Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, Kulkarni R, Gupta S, Gunawardena S, Kouides PA, Brown D, Ragni MV.) J Pediatr Hematol Oncol. 2016 Mar;38(2):139-42 PMID: 26535774 11/05/2015